Literature DB >> 20661664

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Chun-Lei Shi1, Xue-Yan Zhang, Bao-Hui Han, Wei-Zhong He, Jie Shen, Tian-Qing Chu.   

Abstract

The detection and diagnosis of small-sized (2 cm or less) non-small cell lung cancer (NSCLC) has increased with the development of computed tomography (CT). Over 80% of 5-year survival rate has been reported in surgically treated peripheral lung cancer. There are systematic mediastinal and hilar lymph node involvement pleural invasion and intrapulmonary metastasis even with tumor diameter less than 2 cm. The appropriate surgical procedure for such kinds of lung cancer is lobectomy with mediastinal lymph node dissection. To evaluate the prognostic factors and establish the optimal surgical strategy, we analyzed the clinicopathologic features and survival benefit in different tumor size of peripheral small-sized NSCLC. Among the resected lung cancer cases between January 1999 and July 2001, 185 patients were retrospectively analyzed in surgical methods, lymph node involvement, CT scan findings and survival rates. Survival was analyzed by Kaplan-Meier method and log-rank test. Lymph node involvement was recognized in 26(14.05%) patients. There was no statistically significant difference in the incidence of lymph node involvement between tumors 1.6-2.0 cm (17.82%) in diameter than in those 1.0-1.5 cm (11.94%). There was no lymph node metastasis in tumors less than 1.0 cm in diameter. The 5-year survival rates with or without lymph node involvement were 89.98 and 46.15%, respectively, showing significant difference (P=0.000). The overall 5-year survival rate was 83.78%. The 5-year survival rate in tumors 1.6-2.0 cm, 1.0-1.5 cm and less than 1.0 cm in diameter was 80.20, 85.07 and 100%, respectively, and showing significant difference (P=0.035). The 5-year survival rate of 19 patients showing ground-glass opacity (GGO) on CT scan was 94.74% without any metastasis and recurrence after operation. There are systematic mediastinal and hilar lymph node involvement even with tumor diameter less than 2 cm. The results of the present study suggested that systematic lymph node dissection is necessary even for cases with tumor diameter less than 2 cm. However, if the tumor is within 1.0 cm in diameter with obvious GGO showing on chest CT scan, these are good candidates for partial resection without mediastinal lymph node dissection.

Entities:  

Mesh:

Year:  2010        PMID: 20661664     DOI: 10.1007/s12032-010-9632-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  38 in total

1.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.

Authors:  Ken Kodama; Masahiko Higashiyama; Hideoki Yokouchi; Koji Takami; Keiko Kuriyama; Yoko Kusunoki; Tomio Nakayama; Fumio Imamura
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

Review 2.  Video-assisted thoracic surgery (VATS) resection for lung cancer.

Authors:  Scott J Swanson; Hasan F Batirel
Journal:  Surg Clin North Am       Date:  2002-06       Impact factor: 2.741

3.  Symptoms and the early diagnosis of lung cancer.

Authors:  S S Birring; M D Peake
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

Authors:  Junji Yoshida; Kanji Nagai; Tomoyuki Yokose; Mitsuyo Nishimura; Ryutaro Kakinuma; Hironobu Ohmatsu; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

6.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.

Authors:  Haruhisa Matsuguma; Kohei Yokoi; Masaki Anraku; Tetsuro Kondo; Yukari Kamiyama; Kiyoshi Mori; Keigo Tominaga; Yukio Tsuura; Satoshi Honjo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

7.  Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection.

Authors:  Haruhiko Nakamura; Hisashi Saji; Akihiko Ogata; Takamoto Saijo; Shinya Okada; Harubumi Kato
Journal:  Lung Cancer       Date:  2004-04       Impact factor: 5.705

Review 8.  CT screening for lung cancer: update 2007.

Authors:  Claudia I Henschke; David F Yankelevitz
Journal:  Oncologist       Date:  2008-01

9.  Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer.

Authors:  Teruaki Koike; Yasushi Yamato; Katsuo Yoshiya; Satsuki Kina; Takehiko Shimoyama; Ryuta Suzuki; Shuichi Satou; Keiichi Honma
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-10

10.  Peripheral lung adenocarcinomas: 10 mm or less in diameter.

Authors:  Daizo Kondo; Katsuo Yamada; Yasuhiko Kitayama; Shoji Hoshi
Journal:  Ann Thorac Surg       Date:  2003-08       Impact factor: 4.330

View more
  7 in total

Review 1.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

2.  ESR/ERS white paper on lung cancer screening.

Authors:  Hans-Ulrich Kauczor; Lorenzo Bonomo; Mina Gaga; Kristiaan Nackaerts; Nir Peled; Mathias Prokop; Martine Remy-Jardin; Oyunbileg von Stackelberg; Jean-Paul Sculier
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

3.  ESR/ERS white paper on lung cancer screening.

Authors:  Hans-Ulrich Kauczor; Lorenzo Bonomo; Mina Gaga; Kristiaan Nackaerts; Nir Peled; Mathias Prokop; Martine Remy-Jardin; Oyunbileg von Stackelberg; Jean-Paul Sculier
Journal:  Eur Respir J       Date:  2015-04-30       Impact factor: 16.671

4.  Tumor volume is more reliable to predict nodal metastasis in non-small cell lung cancer of 3.0 cm or less in the greatest tumor diameter.

Authors:  Bei Jia; Biao Chen; Hao Long; Tiehua Rong; Xiaodong Su
Journal:  World J Surg Oncol       Date:  2020-07-15       Impact factor: 2.754

5.  Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer.

Authors:  Juan Moreno-Rubio; Santiago Ponce; Rosa Álvarez; María Eugenia Olmedo; Sandra Falagan; Xabier Mielgo; Fátima Navarro; Patricia Cruz; Luis Cabezón-Gutiérrez; Carlos Aguado; Gonzalo Colmenarejo; Marta Muñoz-Fernández de Leglaria; Ana Belén Enguita; María Cebollero; Amparo Benito; Isabel Alemany; Carolina Del Castillo; Ricardo Ramos; Ana Ramírez de Molina; Enrique Casado; Maria Sereno
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

6.  The Study of Tumor Volume as a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: An Exploratory Study.

Authors:  Bei Jia; Xu Zhang; Yunxian Mo; Biao Chen; Hao Long; Tiehua Rong; Xiaodong Su
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Clinical analysis of sixty-four patients with T1aN2M0 stage non-small cell lung cancer who had undergone resection.

Authors:  Jian Xiong; Rui Wang; Yihua Sun; Haiquan Chen
Journal:  Thorac Cancer       Date:  2015-10-06       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.